Trials / Completed
CompletedNCT02327546
Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548
An Open-Label, Randomized, Single-Dose Study to Evaluate the Effects of 325 mg Ferrous Sulfate Tablet (65 mg Iron) on the Pharmacokinetics of 450 mg Dose of AKB-6548 in Healthy Male Volunteers.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Akebia Therapeutics · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to assess the single-dose bioavailability of AKB-6548 with ferrous sulfate relative to AKB-6548 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AKB-6548 | |
| DRUG | Ferrous Sulfate |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2014-12-01
- Completion
- 2015-02-01
- First posted
- 2014-12-30
- Last updated
- 2018-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02327546. Inclusion in this directory is not an endorsement.